Tag: ceo

SOUTH SAN FRANSCISCO, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of  engineered T cell therapeutics that deploy phagocytic mechanisms, announces that the U.S. Food and Drug Administration (FDA) has granted CERo’s Orphan Drug Designation (ODD) for the company's lead drug candidate CER-1236, for the treatment of acute myeloid leukemia (AML). CER-1236 is an innovative therapy that engineers a cancer patient's own T cell therapeutics that deploy phagocytic (i.e., target-cell eating) mechanisms alongside the array of built-in target cell destroying mechanisms used by T cells.

IRVINE, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Tellus Power Globe Holding Limited (“Tellus Power” or the “Company”), a global provider of electric vehicle (EV) charging solutions, today announced the official signing of a joint venture agreement with the renowned BinHendi Holding and SFE Group on May 30, 2025. This move responds to the surging growth of the electric vehicle (EV) market and the urgent need to accelerate e-mobility infrastructure development across the Middle East. This collaboration, supported by the UAE Ministry of Investment (the “Ministry of Investment”), marks the establishment of one of the first EV charging equipment manufacturing companies in the Middle East.